CAR T cells more powerful when built with CRISPR, researchers find – Science Daily
Blasting News |
CAR T cells more powerful when built with CRISPR, researchers find
Science Daily “Cancer cells are relentless in their attempt to evade treatment, so we need CAR T cells that can match and outlast them,” explained Michel Sadelain, MD, PhD, senior author on the Nature paper and Director of the Center for Cell Engineering and the … CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level |
Philadelphia Business Journal |
Why Spark’s CEO says 2017 may be a ‘historic year’ for his gene therapy company
Philadelphia Business Journal Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children … Spark Therapeutics Reports 2016 Financial Results and Business HighlightsGlobeNewswire (press release) |
MIT News |
3Q: US patent office’s ruling on CRISPR
MIT News Q: What is CRISPR, and what research is being done at MIT and the Broad Institute? A: CRISPR is a naturally occurring system by which bacteria and other microorganisms fight viral infections. CRISPR systems, such as CRISPR-Cas9 and CRISPR–Cpf1, … There is more to come in the CRISPR story KQED Future of You Editing the future: A brief introduction to CRISPR |
FierceBiotech |
ImmusanT’s celiac disease immunotherapy passes first clinical test
FierceBiotech ImmusanT’s big idea is to use a trio of three peptides as an immunotherapy that it hopes will encourage the T cells involved in the inflammatory reaction in celiac disease to become tolerant to gluten. After a first course to induce tolerance, the … ImmusanT Announces Completion of Phase 1b Clinical Trial of Nexvax2Business Wire (press release) |